Protalix BioTherapeutics (PLX) Interest Coverage Ratio Growth (1y) (2014 - 2025)
Protalix BioTherapeutics (PLX) Interest Coverage Ratio Growth (1y) (2014 - 2025) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Interest Cover Growth (1y) (Qtr) |
| 1 |
Alterity Therapeutics |
925,601.88 Bn |
925,601.85 Bn |
- |
- |
| 2 |
Belite Bio |
58,560.00 Bn |
58,560.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
17,284.41 Bn |
17,284.40 Bn |
- |
- |
| 4 |
Legend Biotech |
2,809.00 Bn |
2,808.71 Bn |
242.10 Mn |
-76.51% |
| 5 |
Evaxion A |
1,334.43 Bn |
1,334.42 Bn |
- |
18.06% |
| 6 |
Akari Therapeutics |
1,312.27 Bn |
1,312.26 Bn |
- |
-303.06% |
| 7 |
Psyence Biomedical |
212.16 Bn |
212.16 Bn |
- |
75.42% |
| 8 |
Vertex Pharmaceuticals |
114.83 Bn |
107.58 Bn |
2.59 Bn |
- |
| 9 |
Abivax |
91.96 Bn |
91.96 Bn |
- |
67.94% |
| 10 |
Protalix BioTherapeutics |
176.47 Mn |
165.67 Mn |
29.62 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2025 |
-5,448.29% |
| Dec 31, 2024 |
2,523.72% |
| Sep 30, 2024 |
474.19% |
| Jun 30, 2024 |
-140.92% |
| Mar 31, 2024 |
-228.62% |
| Dec 31, 2023 |
-162.91% |
| Sep 30, 2023 |
16.12% |
| Jun 30, 2023 |
276.48% |
| Mar 31, 2023 |
-25.22% |
| Dec 31, 2022 |
283.51% |
| Sep 30, 2022 |
-525.25% |
| Jun 30, 2022 |
-113.11% |
| Mar 31, 2022 |
-76.08% |
| Dec 31, 2021 |
-658.02% |
| Sep 30, 2021 |
40.23% |
| Jun 30, 2021 |
-261.83% |
| Mar 31, 2021 |
-218.24% |
| Dec 31, 2020 |
6.93% |
| Sep 30, 2020 |
-73.75% |
| Jun 30, 2020 |
62.44% |
